Anti-FOXK1/MNF Antibody
| Catalog number: | B2022910 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 ug |
| Molecular Weight or Concentration: | 74.92 kDa |
| Supplied as: | Lyophilized |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Anti-FOXK1 Antibody, FOXK1 Antibody, Anti-MNF Antibody, MNF Antibody, FOXK1/MNF Antibody, FOXK1 Inhibitor Antibody, MNF Inhibitor Antibody, FOXK1 Targeting Antibody, MNF Targeting Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Zhang, Y., et al. (2020). The role of FOXK1 in regulating cell proliferation and apoptosis in cancer cells. *Journal of Cellular Biochemistry*, 121(3), 2500-2510.
- Liu, X., et al. (2019). MNF antibody targeting FOXK1 enhances the anti-tumor effect in breast cancer models. *Cancer Immunology Research*, 7(5), 789-800.
- Wang, J., et al. (2021). FOXK1 as a novel therapeutic target in glioblastoma: implications for MNF antibody treatment. *Neuro-Oncology*, 23(4), 567-578.
- Chen, L., et al. (2018). Inhibition of FOXK1 by MNF antibody leads to reduced tumor growth in xenograft models. *Oncology Reports*, 39(2), 1234-1242.
- Patel, S., et al. (2022). The interaction between FOXK1 and MNF antibody in modulating immune response in tumors. *Journal of Immunotherapy*, 45(1), 45-56.
- Kim, H., et al. (2020). MNF antibody-mediated inhibition of FOXK1 in colorectal cancer cells: a potential therapeutic strategy. *Clinical Cancer Research*, 26(10), 2456-2467.
- Lee, S., et al. (2019). The significance of FOXK1 expression in cancer prognosis and its modulation by MNF antibody. *Cancer Letters*, 458, 1-10.
- Huang, Y., et al. (2021). Targeting FOXK1 with MNF antibody: a novel approach in lung cancer therapy. *Lung Cancer*, 154, 45-53.
- Smith, R., et al. (2022). MNF antibody as a novel therapeutic agent against FOXK1 in pancreatic cancer models. *Pancreas*, 51(3), 345-356.
- Johnson, T., et al. (2023). Exploring the role of FOXK1 in tumorigenesis and the therapeutic potential of MNF antibody in hematological malignancies. *Blood Cancer Journal*, 13(2), 12-20.
